Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution
Copyright © 2021. Published by Elsevier Inc..
Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we include realistic prepandemic and recently recorded contact patterns between age groups. The implementation of non-pharmaceutical interventions will occur on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. In order to account for spatial heterogeneity, we use a graph approach and we include high-quality information on commuting activities combined with traveling information from social networks. The remaining uncertainty will be accounted for by a large number of randomized simulation runs. Based on the derived factors for the effectiveness of different non-pharmaceutical interventions over the past months, we provide different forecast scenarios for the upcoming time.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:339 |
---|---|
Enthalten in: |
Mathematical biosciences - 339(2021) vom: 15. Sept., Seite 108648 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kühn, Martin J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Coronavirus disease |
---|
Anmerkungen: |
Date Completed 16.08.2021 Date Revised 02.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.mbs.2021.108648 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32763295X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32763295X | ||
003 | DE-627 | ||
005 | 20231225201222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mbs.2021.108648 |2 doi | |
028 | 5 | 2 | |a pubmed24n1092.xml |
035 | |a (DE-627)NLM32763295X | ||
035 | |a (NLM)34216635 | ||
035 | |a (PII)S0025-5564(21)00084-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kühn, Martin J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.08.2021 | ||
500 | |a Date Revised 02.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021. Published by Elsevier Inc. | ||
520 | |a Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we include realistic prepandemic and recently recorded contact patterns between age groups. The implementation of non-pharmaceutical interventions will occur on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. In order to account for spatial heterogeneity, we use a graph approach and we include high-quality information on commuting activities combined with traveling information from social networks. The remaining uncertainty will be accounted for by a large number of randomized simulation runs. Based on the derived factors for the effectiveness of different non-pharmaceutical interventions over the past months, we provide different forecast scenarios for the upcoming time | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Coronavirus disease | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Forecast | |
650 | 4 | |a Mitigation | |
650 | 4 | |a Non-pharmaceutical interventions | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Abele, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Mitra, Tanmay |e verfasserin |4 aut | |
700 | 1 | |a Koslow, Wadim |e verfasserin |4 aut | |
700 | 1 | |a Abedi, Majid |e verfasserin |4 aut | |
700 | 1 | |a Rack, Kathrin |e verfasserin |4 aut | |
700 | 1 | |a Siggel, Martin |e verfasserin |4 aut | |
700 | 1 | |a Khailaie, Sahamoddin |e verfasserin |4 aut | |
700 | 1 | |a Klitz, Margrit |e verfasserin |4 aut | |
700 | 1 | |a Binder, Sebastian |e verfasserin |4 aut | |
700 | 1 | |a Spataro, Luca |e verfasserin |4 aut | |
700 | 1 | |a Gilg, Jonas |e verfasserin |4 aut | |
700 | 1 | |a Kleinert, Jan |e verfasserin |4 aut | |
700 | 1 | |a Häberle, Matthias |e verfasserin |4 aut | |
700 | 1 | |a Plötzke, Lena |e verfasserin |4 aut | |
700 | 1 | |a Spinner, Christoph D |e verfasserin |4 aut | |
700 | 1 | |a Stecher, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Xiao Xiang |e verfasserin |4 aut | |
700 | 1 | |a Basermann, Achim |e verfasserin |4 aut | |
700 | 1 | |a Meyer-Hermann, Michael |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mathematical biosciences |d 1978 |g 339(2021) vom: 15. Sept., Seite 108648 |w (DE-627)NLM012638099 |x 1879-3134 |7 nnns |
773 | 1 | 8 | |g volume:339 |g year:2021 |g day:15 |g month:09 |g pages:108648 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mbs.2021.108648 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 339 |j 2021 |b 15 |c 09 |h 108648 |